Skip to content

LIMA Protocol Towards Palatal Fistula and Maxillary Growth in Cleft Palate

LIMA Protocol Towards Palatal Fistula and Maxillary Growth in Cleft Palate: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07137169
Enrollment
35
Registered
2025-08-22
Start date
2022-01-01
Completion date
2024-12-31
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleft Palate, Fistula of Soft Palate (Disorder), Maxillar Hypoplasia

Keywords

LIMA Protocol, cleft palate, palatoplasty, cleft palate repair, palatal fistula, maxillary growth restriction

Brief summary

This randomized controlled trial compared palatoplasty outcomes using the LIMA protocol (Hybrid and one-flap techniques) versus the RSCM protocol (two-flap technique) in patients with unilateral Veau III-IV cleft palate at Cipto Mangunkusumo Hospital from January 2022 to December 2024.

Detailed description

Background: Palatoplasty in patients with cleft palate carries risks of palatal fistula and impaired maxillary growth, both of which are influenced by cleft severity and surgical technique. The LIMA protocol offers a refined classification and tailored surgical approach, with promising results in reducing these complications. Methods: This study is a randomized controlled trial comparing palatoplasty techniques based on the LIMA protocol (Hybrid and one-flap techniques) versus the RSCM protocol (two-flap technique) in terms of surgical outcomes: palatal fistula and maxillary growth. The study was conducted at Cipto Mangunkusumo Hospital (RSCM) from January 2022 to December 2024. Samples were collected consecutively, with all subjects who met the inclusion criteria (patients aged 9 months-2 years with unilateral Veau III-IV cleft palate undergoing primary palatoplasty at RSCM) randomly allocated into two study groups. Data were analyzed using T-test and Mann-Whitney U test.

Interventions

PROCEDURELIMA protocol

Cleft palate repair using Hybrid / One-flap technique

PROCEDURERSCM Protocol

Cleft palate repair using Two-flap technique

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
9 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

* Patients with complete unilateral cleft lip and palate aged 9 months to 2 years who agreed to be research subjects * Patients with complete unilateral cleft lip and palate who underwent palatoplasty surgery at Cipto Mangunkusumo Hospital

Exclusion criteria

* Patients who refuse to be research subjects and do not want to sign consent form * Patients with complete unilateral cleft lip and palate who have previously undergone cleft palate repair/ palatoplasty

Design outcomes

Primary

MeasureTime frameDescription
Maxillary Size Indicators Observed From Dental CastsFrom the time of surgery until 6 months post-operativelyMaxillary growth is assessed by measuring its size based on indicators obtained from dental casts before surgery, 1 month post-surgery, and 6 months post-surgery. There will be 4 indicators, namely: 1. 'CC = primary inter-canine width 2. 'TT = inter-tuberosity width 3. 'ICC = length from incisivus to the 'CC line (indicating anterior palatal length) 4. 'ITT = length from incisivus to the 'TT line (indicating overall palatal length)
Palatal Fistula by Pittsburgh ClassificationFrom the time of surgery until 6 months post-operativelyA palatal fistula is an abnormal opening in the palate that persists or develops after cleft palate repair, creating a connection between the oral and nasal cavities, excluding openings due to wound/ suture dehiscence. The location of opening will be Classified using Pittsburgh Classification; Type I: uvula; Type II: soft palate; Type III: junction between the soft and hard palate; Type IV: hard palate; Type V: junction between the primary and secondary palate; Type VI: lingual-alveolar; Type VII: labial-alveolar.

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026